Another therapeutic strategy would be targeting the paracrine signalling factors such as the CAFs-secreted TGF-β and CXCL12, and cancer cells derived PDGF-α/β, b-FGF, and IL-6 that could lead to CAFs activation [20,86,150]. The gene discussed is TGFB1; the disease is cancer.